Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2017

View Archived Issues

GlaxoSmithKline offers pipeline progress report for first quarter 2017

Rigel describes novel JAK inhibitors

Medeor obtains IND clearance and SPA agreement with the FDA for phase III trial of MDR-101

Tesaro submits IND for TSR-033

Sunesis to withdraw MAA for vosaroxin in AML

Concert Pharmaceuticals initiates phase II trial of CTP-543 in alopecia areata

Corvus expands CPI-444 collaboration with Genentech

FDA grants fast track designation to ALT-803 as treatment for non-muscle invasive bladder cancer

FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture

Sanofi presents first-in-human data for the humanized anti-CD52 antibody GLD-52

Pieris and AstraZeneca establish respiratory disease collaboration

ZED-1227 for celiac disease completes phase Ib study

Mutations in NFKBIA found to confer resistance to multiple sclerosis treatment with MIS-416

FDA accepts IND for phase II trial of GKT-831 in primary biliary cholangitis

Agency for Science, Technology and Research (A*STAR) patents SMYD3 inhibitors

NIAID grant supports Lyndra's development of ultra-long acting HIV therapy

Selecta licenses LMB-100 from National Cancer Institute

FDA approves Ventana PD-L1 Assay as companion diagnostic for Imfinzi

Abivax reports effect of ABX-464 on HIV blood reservoir in phase IIa study

Gruenenthal identifies Cav2.2 channel blockers

French researchers present azaphenantrene analogues

FDA grants regenerative medicine advanced therapy designation to jCell

Sosei obtains equity stake and option to acquire MiNA Therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...